BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3059277)

  • 1. [Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients].
    Maraninchi D; Hartman O; Benhamou E; Viens P; Blaise D; Vassal G; Gaspard MH; Kalifa C; Stoppa AM; Patte C
    Pathol Biol (Paris); 1988 Sep; 36(7):915-9. PubMed ID: 3059277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin].
    Rubie H; Attal M; Lemozy J; Massip P; Huguet F; Pris J; Robert A; Régnier C
    Pathol Biol (Paris); 1988 Sep; 36(7):912-4. PubMed ID: 3059276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
    Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
    Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.
    Attal M; Schlaifer D; Rubie H; Huguet F; Charlet JP; Bloom E; Lemozy J; Massip P; Pris J; Laurent G
    J Clin Oncol; 1991 May; 9(5):865-70. PubMed ID: 2016630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of bacterial infections after bone marrow graft by broad-spectrum oral antibiotics, absorbable (pefloxacin, penicillin) and non absorbable (cephalosporin, gentamycin, bacitracin)].
    Gluckman E; Cavazzana M; Devergie A; Meletis J; Arlet G; Perol Y; Boiron M
    Pathol Biol (Paris); 1988 Sep; 36(7):902-6. PubMed ID: 3059274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early septicemia episodes in 143 bone marrow grafts].
    Marit G; Texier J; Reiffers J
    Pathol Biol (Paris); 1988 Sep; 36(7):899-901. PubMed ID: 3059273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteremias after bone marrow grafts in a protected environment: effects, various aspects and prognosis].
    Michel G; Maraninchi D; Blaise D; Stoppa AM; Gastaut JA; Camerlo J; Gaspard MH; Novakovitch G; Carcassonne Y
    Pathol Biol (Paris); 1988 Sep; 36(7):891-5. PubMed ID: 3059271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
    Hosen N; Teshima H; Karasuno T; Ujiie H; Nakao T; Yagi T; Hatanaka K; Kawamoto S; Hiraoka A; Nakamura H; Masaoka T
    Rinsho Ketsueki; 1999 Jan; 40(1):9-15. PubMed ID: 10067090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis.
    Vassilomanolakis M; Plataniotis G; Koumakis G; Hajichristou H; Skouteri H; Dova H; Efremidis AP
    Bone Marrow Transplant; 1995 Jan; 15(1):77-80. PubMed ID: 7742759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid for the treatment of complicated skin and skin structure infections in children.
    Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients.
    Schuler U; Ehninger G
    Bone Marrow Transplant; 1994; 14 Suppl 4():S61-5. PubMed ID: 7728128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early bacterial infections after allogenic bone marrow grafts].
    Guyotat D; Plotton C; Archimbaud E; Fiere D; Fleurette J
    Pathol Biol (Paris); 1988 Sep; 36(7):896-8. PubMed ID: 3059272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infections and bone marrow autograft carried out for leukemias in children. Apropos of 47 cases].
    Amsallem D; Plouvier E; Estavoyer JM; Leroy J; Talon D; Lab M; Hervé P; Noir A
    Arch Fr Pediatr; 1988; 45(6):393-7. PubMed ID: 3064729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
    Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course.
    Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D
    Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
    Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
    Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.